General Electric
http://www.ge.com
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From General Electric
Asia Deal Watch: IProGen To Partner With Rani On GLP-2 Agonist In Obesity
Plus deals involving Healios/Astellas Institute for Regenerative Medicine, Otsuka/Ionis, IMBiologics/Navigator and more.
India Pharma Chiefs On Supply Chain Learnings From Auto Sector, New ‘PAGE’ On Skilling
Leaders from India’s top drug makers discuss efforts to operationalize a world-class skilling institute, backed by tie-ups with organizations like the PDA, ISPE and also taking a leaf out of the automobile industry’s book to build supply chain resilience. They also exuded confidence on moving up the innovation value chain.
Why US Payers Aren’t Reimbursing Obesity Meds
Payers are restricting access to obesity drugs due to huge patient numbers and a wave of innovation in other areas
Sanofi Secures World First Approval For Dupixent In COPD With EU Nod
The French drugmaker can now boast seven approvals for its huge-earning IL-4/IL-13 inhibitor.
Company Information
- Industry
- Diversified
- Medical Devices
- Other Names / Subsidiaries
-
- Amersham
- Clarient Inc.
- Asymptote Limited
- GE Healthcare
- GE Medical Systems LLC
- Monica Healthcare
- Novia Strategies
- Vital Signs.
- Xcellerex
- U-Systems
- Zionexa SAS
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice